Cardiovascular disease in individuals with spinal cord injury: Toward best practice

Topics in Spinal Cord Injury Rehabilitation

Volumn 14, Issue 3, 2009, Pages 84-98

  Groah, Suzanne L ^a,b   Spungen, Miriam I ^a   Bauman, William A ^c,d  

^a NATIONAL REHABILITATION HOSPITAL   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Carbohydrate disorders; Cardiovascular disease; Lipid disorders; Spinal cord injury

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL PRACTICE; DISABLED PERSON; DYSLIPIDEMIA; EVIDENCE BASED PRACTICE; HEALTH CARE SYSTEM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPINAL CORD INJURY;

EID: 59849103830     PISSN: 10820744     EISSN: None     Source Type: Journal    
DOI: 10.1310/sci1403-84     Document Type: Review

References (101)

1. American Heart Association. Heart Disease and Stroke Statistics - 2006 Update. Dallas, TX: American Heart Association; 2006.
2. Hoyert DL, Heron MP, Murphy SL, Kung H. Deaths: Final Data for 2003. National Vital Statistics Reports; vol. 54 no. 13. Hyattsville, MD: National Center for Heatlh Statistics; 2006.
3. Whiteneck GG, Charlifue SW, Gerhart KA, et al., eds. Aging with Spinal Cord Injury. New York: Demos; 1993.
4. DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999;80:1411-1419.
5. Garshick E, Kelley A, Cohen SA, Garrison A, Tun CG, Gagnon D, Brown R. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord. 2005;43(7):408-416.
6. Bauman WA, Spungen AM. Carbohydrate and lipid metabolism in chronic spinal cord injury. J Spinal Cord Med. 2001;24:266-277.
7. Orakzai SH, Orakzai RH, Ahmadi N, et al. Measurement of coronary artery calcification by electron beam computerized tomography in persons with chronic spinal cord injury: Evidence for increased atherosclerotic burden. Spinal Cord. 2007;45:775-779.
8. Wilt TJ, Carlson FK, Goldish GD, et al. Carbohydrate and lipid disorders and relevant considerations in persons with spinal cord injury. Evidence Report/Technology Assessment No. 163 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publications No. 08-E0005. Rockville, MD: Agency for Healthcare Research and Quality; January 2008.
9. Sackett DL. Inference and decision at the bedside. J Clin Epidemiol. 1989;42(4):309-316.
10. Greenhalgh T. How to read a paper: Papers that summarize other papers (systematic reviews and meta-analyses). Br Med J. 1997;315:672-675.
11. Bauman WA, Raza M, Chayes Z, Machac J. Tomographic thallium-201 myocardial perfusion imaging after intravenous dipyridamole in asymptomatic subjects with quadriplegia. Arch Phys Med Rehabil. 1993;74(7):740-744.
12. Bauman WA, Raza M, Spungen AM, Machac J. Cardiac stress testing with thallium-201 imaging reveals silent ischemia in individuals with paraplegia. Arch Phys Med Rehabil. 1994;75(9):946-950.
13. Bauman WA, Spungen AM, Raza M, et al. Coronary artery disease: Metabolic risk factors and latent disease in individuals with paraplegia. Mt Sinai J Med. 1992;59(2):163-168.
14. Bauman WA, Spungen AM, Zhong YG, Mobbs CV. Plasma leptin is directly related to body adiposity in subjects with spinal cord injury. Horm Metab Res. 1996;28(12):732-736.
15. Blackmer J, Marshall S. Obesity and spinal cord injury: An observational study. Spinal Cord. 1997;35(4):245-247.
16. Bostom AG, Toner MM, McArdle WD, Montelione T, Brown CD, Stein RA. Lipid and lipoprotein profiles relate to peak aerobic power in spinal cord injured men. Med Sci Sports Exerc. 1991;23(4):409-414.
17. Burstein R, Zeilig G, Royburt M, Epstein Y, Ohry A. Insulin resistance in paraplegics - effect of one bout of acute exercise. Int J Sports Med. 1996;17(4):272-276.
18. Chen Y, Henson S, Jackson AB, Richards JS. Obesity intervention in persons with spinal cord injury. Spinal Cord. 2006;44(2):82-91.
19. Curtis KA, McClanahan S, Hall KM, Dillon D, Brown KF. Health, vocational, and functional status in spinal cord injured athletes and nonathletes. Arch Phys Med Rehabil. 1986;67(12):862-865.
20. Duckworth WC, Jallepalli P, Solomon SS. Glucose intolerance in spinal cord injury. Arch Phys Med Rehabil. 1983;64(3):107-110.
21. Duckworth WC, Solomon SS, Jallepalli P, Heckemeyer C, Finnern J, Powers A. Glucose intolerance due to insulin resistance in patients with spinal cord injuries. Diabetes. 1980;29(11):906-910.
22. Elder CP, Apple DF, Bickel CS, Meyer RA, Dudley GA. intramuscular fat and glucose tolerance after spinal cord injury - a cross-sectional study. Spinal Cord. 2004;42(12):711-716.
23. El-Sayed MS, Younesian A. Lipid profiles are influenced by arm cranking exercise and training in individuals with spinal cord injury. Spinal Cord. 2005;43(5):299-305.
24. Haldi PA. Double trouble: Diabetes and SCI. SCI Nurs. 2003;20(2):106-108.
25. Janssen TW, van Oers CA, van Kamp GJ, TenVoorde BJ, van der Woude LH, Hollander AP. Coronary heart disease risk indicators, aerobic power, and physical activity in men with spinal cord injuries. Arch Phys Med Rehabil. 1997;78(7):697-705.
26. Jeon JY, Weiss CB, Steadward RD, et al. Improved glucose tolerance and insulin sensitivity after electrical stimulation-assisted cycling in people with spinal cord injury. Spinal Cord. 2002;40(3):110-117.
27. Jones LM, Legge M, Goulding A. Healthy body mass index values often underestimate body fat in men with spinal cord injury. Arch Phys Med Rehabil. 2003;84(7):1068-1071.
28. Jones LM, Legge M, Goulding A. Factor analysis of the metabolic syndrome in spinal cord-injured men. Metabolism. 2004;53(10):1372-1377.
29. Karlsson AK. Insulin resistance and sympathetic function in high spinal cord injury. Spinal Cord. 1999;37(7):494-500.
30. Karlsson AK, Attvall S, Jansson PA, Sullivan L, Lonnroth P. Influence of the sympathetic nervous system on insulin sensitivity and adipose tissue metabolism: A study in spinal cord-injured subjects. Metabolism. 1995;44(1):52-58.
31. Karlsson AK, Elam M, Friberg P, Biering-Sorensen F, Sullivan L, Lonnroth P. Regulation of lipolysis by the sympathetic nervous system: A microdialysis study in normal and spinal cord-injured subjects. Metabolism. 1997;46(4):388-394.
32. Leaf DA, Bahl RA, Adkins RH. Risk of cardiac dysrhythmias in chronic spinal cord injury patients. Paraplegia. 1993;31(9):571-575.
33. Lee CS, Lu YH, Lee ST, Lin CC, Ding HJ. Evaluating the prevalence of silent coronary artery disease in asymptomatic patients with spinal cord injury. Int Heart J. 2006;47(3):325-330.
34. Lee MY, Myers J, Hayes A, et al. C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury. J Spinal Cord Med. 2005;28(1):20-25.
35. Maki KC, Briones ER, Langbein WE, et al. Associations between serum lipids and indicators of adiposity in men with spinal cord injury. Paraplegia. 1995;33(2):102-109.
36. Manns PJ, McCubbin JA, Williams DP. Fitness, inflammation, and the metabolic syndrome in men with paraplegia. Arch Phys Med Rehabil. 2005;86(6):1176-1181.
37. Mohr T, Dela F, Handberg A, Biering-Sorensen F, Galbo H, Kjaer M. Insulin action and long-term electrically induced training in individuals with spinal cord injuries. Med Sci Sports Exerc. 2001;33(8):1247-1252.
38. Myllynen P, Koivisto VA, Nikkila EA. Glucose intolerance and insulin resistance accompany immobilization. Acta Medica Scandinavica. 1987;222(1):75-81.
39. Nash MS, DeGroot J, Martinez-Arizala A, Mendez AJ. Evidence for an exaggerated postprandial lipemia in chronic paraplegia. J Spinal Cord Med. 2005;28(4):320-325.
40. Nash MS, Jacobs PL, Mendez AJ, Goldberg RB. Circuit resistance training improves the atherogenic lipid profiles of persons with chronic paraplegia. J Spinal Cord Med. 2001;24(1):2-9.
41. Nash MS, Johnson BM, Jacobs PL. Combined hyperlipidemia in a single subject with tetraplegia: Ineffective risk reduction after atorvastatin monotherapy. J Spinal Cord Med. 2004;27(5):484-487.
42. Ozgurtas T, Alaca R, Gulec M, Kutluay T. Do spinal cord injuries adversely affect serum lipoprotein profiles? Mil Med. 2003;168(7):545-547.
43. Phillips SM, Stewart BG, Mahoney DJ, et al. Body-weight-support treadmill training improves blood glucose regulation in persons with incomplete spinal cord injury. J Appl Physiol. 2004;97(2):716-724.
44. Shetty KR, Sutton CH, Rudman IW, Rudman D. Lipid and lipoprotein abnormalities in young quadriplegic men. Am J Med Sci. 1992;303(4):213-216.
45. Vaziri ND, Gordon S, Nikakhtar B. Lipid abnormalities in chronic renal failure associated with spinal cord injury. Paraplegia. 1982;20(3):183-189.
46. Wong PY, Wang YC, Chu NK, Tang FT, Wong MK. Body weight, serum uric acid and lipid profile one year after spinal cord injury. Chang Gung Med J. 2001;24(9):569-575.
47. Yekutiel M, Brooks ME, Ohry A, Yarom J, Carel R. The prevalence of hypertension, ischaemic heart disease and diabetes in traumatic spinal cord injured patients and amputees. Paraplegia. 1989;27(1):58-62.
48. Zlotolow SP, Levy E, Bauman WA. The serum lipoprotein profile in veterans with paraplegia: The relationship to nutritional factors and body mass index. J Am Paraplegia Soc. 1992;15(3):158-162.
49. Alaedeen DI, Jasper J. Gastric bypass surgery in a paraplegic morbidly obese patient. Obes Surg. 2006;16(8):1107-1108.
50. Ball R. Effect of severity, time to recompression with oxygen, and re-treatment on outcome in forty-nine cases of spinal cord decompression sickness. Undersea Hyperb Med. 1993;20(2):133-145.
51. Barlascini CO, Schmitt JK, Adler RA. Insulin pump treatment of type I diabetes mellitus in a patient with C6 quadriplegia. Arch Phys Med Rehabil. 1989;70(1):58-60.
52. Beck LA. Morbid obesity and spinal cord injury: A case study. SCI Nurs. 1998;15(1):3-5.
53. Carver RT, Boysel LC, Marciniak CM, Nussbaum SB. Myotonic dystrophy presenting as new-onset hand weakness and recurrent pneumonia in a patient with paraplegia: A case report. Arch Phys Med Rehabil. 2004;85(11):1896-1898.
54. Chen CJ, Fang W, Chen CM, Wan YL. Spontaneous spinal epidural haematomas with repeated remission and relapse. Neuroradiology. 1997;39(10):737-740.
55. Claydon VE, Elliott SL, Sheel AW, Krassioukov A. Cardiovascular responses to vibrostimulation for sperm retrieval in men with spinal cord injury. J Spinal Cord Med. 2006;29(3):207-216.
56. Courtois F, Geoffrion R, Landry E, Belanger M. H-reflex and physiologic measures of ejaculation in men with spinal cord injury. Arch Phys Med Rehabil. 2004;85(6):910-918.
57. Dela F, Stallknecht B, Biering-Sorensen F. An intact central nervous system is not necessary for insulin-mediated increases in leg blood flow in humans. Pflugers Arch. 2000;441(2-3):241-250.
58. Do Ouro S, Esteban S, Sibirceva U, Wittenberg B, Portenoy R, Cruciani RA. Safety and tolerability of high doses of intrathecal fentanyl for the treatment of chronic pain. J Opioid Manag. 2006;2(6):365-368.
59. Franga DL, Hawkins ML, Medeiros RS, Adewumi D. Recurrent asystole resulting from high cervical spinal cord injuries. Am Surg. 2006;72(6):525-529.
60. Fujii Y, Mammen EF, Farag A, Muz J, Salciccioli GG, Weingarden ST. Thrombosis in spinal cord injury. Thromb Res. 1992;68(4-5):357-368.
61. Fuller DA, Mark A, Keenan MA. Excision of heterotopic ossification from the knee: A functional outcome study. Clin Orthop Relat Res. 2005;438:197-203.
62. Pahl MV, Vaziri ND, Gonzales E. Coagulation profile in persons with long-standing spinal cord injury. J Am Paraplegia Soc. 1994;17(3):133-135.
63. Perkash A, Sullivan G, Toth L, Bradleigh LH, Linder SH, Perkash I. Persistent hypercoagulation associated with heterotopic ossification in patients with spinal cord injury long after injury has occurred. Paraplegia. 1993;31(10):653-659.
64. Rittenberg JD, Burns SP, Little JW. Worsening myelopathy masked by peripheral nerve disorders. J Spinal Cord Med. 2004;27(1):72-77.
65. Schizas C, Ballesteros C, Roy P. Cauda equine compression after trauma: An unusual presentation of spinal epidural lipoma. Spine. 2003;28(8):E148-151.
66. Silver JR, Noori Z. Pulmonary embolism following anticoagulation therapy. Int Disabil Stud. 1991;13(1):16-19.
67. Strachan RK, Cook J, Wilkie W, Kennedy NS. An evaluation of pneumatic orthoses in thoracic paraplegia. Paraplegia. 1985;23(5):295-305.
68. Telfeian AE, Reiter GT, Durham SR, Marcotte P. Spine surgery in morbidly obese patients. J Neurosurg. 2002;97(1 Suppl):20-24.
69. Walker WA, Evans BJ, Pate JW, Weiman DS, Riddle JC. Coronary operations in patients with spinal cord injury. Ann Thorac Surg. 1996;61(3):789-794.
70. Mehrholz J, Kugler J, Pohl M. Locomotor training for walking after spinal cord injury. Cochrane Database Syst Rev. 2008;(2):CD006676.
71. Chinnock P, Roberts I. Gangliosides for acute spinal cord injury. Cochrane Database of Syst Rev. 2005;(2):CD004444. DOI:10.1002/14651858. CD004444.pub2.
72. Maki KC, Briones ER, Langbein WE, Inman-Felton A, Nemchausky B, Welch M, Burton J. Associations between serum lipids and indicators of adiposity in men with spinal cord injury. Paraplegia. 1995;33:102-109.
73. Levine AM, Nash MS, Green BA, Shea JD, Aronica MJ. An examination of dietary intakes and nutritional status of chronic healthy spinal cord injured individuals. Paraplegia. 1992;30:880-889.
74. Duckworth WC, Solomon SS, Jallepalli P, Heckemeyer C, Finnern J, Powers A. Glucose intolerance due to insulin resistance in patients with spinal cord injuries. Diabetes. 1980;29:906-910.
75. Karlsson AK. Insulin resistance and sympathetic function in high spinal cord injury. Spinal Cord. 1999;37:494-500.
76. Karlsson AK, Attvall S, Jansson PA, Sullivan L, Lonnroth P. Influence of the sympathetic nervous system on insulin sensitivity and adipose tissue metabolism: A study in spinal cord-injured subjects. Metabolism. 1995;44:52-58.
77. Bauman WA, Spungen AM. Metabolic changes in persons after spinal cord injury. Phys Med Rehabil Clin N Am. 2000;11:109-140.
78. Carnethon MR, Gidding SS, Nehgme R, Sidney S, Jacobs DR, Liu K. Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA. 2003;290:3092-3100.
79. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering. Arch Intern Med. 2008;168:1617-1624.
80. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999;282:1547-1553.
81. Lee SJ, Kub JL, Katzmarzyk PT, Blair SN, Church TS, Ross R. Cardiopulmonary fitness attenuates metabolic risk independent of abdominal subcutaneous and visceral fat in man. Diabetes Care. 2005;28:895-901.
82. Yki-Jarvinen H, Koivisto VA. Effects of body composition on insulin sensitivity. Diabetes. 1983;32:965-969.
83. Bauman WA, Spungen AM. Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: A model of premature aging. Metabolism. 1994;43:749-756.
84. Weaver FM, Collins EG, Kurichi J, et al. Prevalence of obesity and high blood pressure in veterans with spinal cord injuries and disorders: A retrospective review. Am J Phys Med Rehabil. 2007;86(1):22-29.
85. Gupta N, White KT, Sandford PR. Body mass index in spinal cord injury - a retrospective study. Spinal Cord. 2006;44(2):92-94.
86. Johnston MV, Diab ME, Chu BC, Kirshblum S. Preventive services and health behaviors among people with spinal cord injury. J Spinal Cord Med. 2005;28(1):43-54.
87. Zhong YG, Levy E, Bauman WA. The relationships among serum uric acid, plasma insulin, and serum lipoprotein levels in subjects with spinal cord injury. Horm Metab Res. 1995;27(6):283-286.
88. Bauman WA, Adkins RH, Spungen AM, Waters RL. The effect of residual neurological deficit on oral glucose tolerance in persons with chronic spinal cord injury. Spinal Cord. 1999;37(11):765-771.
89. Bauman WA, Spungen AM, Zhong YG, Rothstein JL, Petry C, Gordon SK. Depressed serum high density lipoprotein cholesterol levels in veterans with spinal cord injury. Paraplegia. 1992;30(10):697-703.
90. Spungen AM, Adkins RH, Stewart CA, Wang J, Pierson RN Jr, Waters RL, Bauman WA. Factors influencing body composition in persons with spinal cord injury: A cross-sectional study. J Appl Physiol. 2003;95(6):2398-2407.
91. Krum H, Howes LG, Brown DJ, Ungar G, Moore P, McNeil JJ, Louis WJ. Risk factors for cardiovasculardisease in chronic spinal cord injury patients. Paraplegia. 1992;30(6):381-388.
92. Brenes G, Dearwater S, Shapera R, LaPorte RE, Collins E. High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients. Arch Phys Med Rehabil. 1986;67:445-450.
93. Bauman WA, Adkins RH, Spungen AM, et al. Is immobilization associated with an abnormal lipoprotein profile? Observations from a diverse cohort. Spinal Cord. 1999;37:485-493.
94. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med. 2002;162(16):1867-1872.
95. Centers for Disease Control and Prevention. Overweight and Obesity. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/. Accessed July 1, 2008.
96. Rexrode KM, Hennekens CH, Willett WC, et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA. 1997;277(19):1539-1545.
97. National Cholesterol Education Panel. Third Report of the National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Circulation. 2002;106:3143-3421.
98. Weaver FM, Collins EF, Kurichi J, et al. Prevalence of obesity and high blood pressure in veterans with spinal cord injuries and disorders: A retrospective review. Am J Phys Med Rehabil. 2007;86:22-29.
99. Groah SL, Weitzenkamp D, Sett P, Soni B, Savic G. The relationship between neurological level of injury and symptomatic cardiovascular disease risk in the aging spinal injured. Spinal Cord. 2001;39:310-317.
100. Siragy HM. Evidence for benefits of angiotensin receptor blockade beyond blood pressure control. Curr Hypertens Rep. 2008;10:261-267.
101. Canadian Institutes of Health Research. About knowledge translation: The KT Portfolio at CIHR. Ottawa, Ontario, Canada: Canadian Institutes of Health Research. Available at: http://www.cihr-irsc.gc.ca/e/29418.html. Accessed February 12, 2008.